Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Primary low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion.

Rubinstein JC, Visa A, Zhang L, Antonescu CR, Christison-Lagay ER, Morotti R.

Pediatr Dev Pathol. 2014 Jul-Aug;17(4):321-6. doi: 10.2350/14-05-1487-CR.1. Epub 2014 Jun 4.

PMID:
24896634
2.

Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.

Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG, Mertens F.

Am J Surg Pathol. 2014 Jun;38(6):801-8. doi: 10.1097/PAS.0000000000000158.

PMID:
24441665
3.

EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.

Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK.

Am J Surg Pathol. 2013 May;37(5):734-8. doi: 10.1097/PAS.0b013e31827560f8.

PMID:
23588368
4.

Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.

Mohamed M, Fisher C, Thway K.

Ann Diagn Pathol. 2017 Jun;28:60-67. doi: 10.1016/j.anndiagpath.2017.04.001. Epub 2017 Apr 5. Review.

PMID:
28648941
5.

A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.

Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA, Antonescu CR.

Genes Chromosomes Cancer. 2015 Jan;54(1):28-38. doi: 10.1002/gcc.22215. Epub 2014 Sep 18.

6.

Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.

Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchère-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marquès B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F, Coindre JM.

Am J Surg Pathol. 2007 Sep;31(9):1387-402.

PMID:
17721195
7.

Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.

Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I.

Lab Invest. 2005 Mar;85(3):408-15.

8.

Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.

Thway K, Chisholm J, Hayes A, Swansbury J, Fisher C.

Hum Pathol. 2015 Mar;46(3):461-6. doi: 10.1016/j.humpath.2014.11.004. Epub 2014 Nov 26.

PMID:
25532939
9.

Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.

Matsuyama A, Hisaoka M, Shimajiri S, Hayashi T, Imamura T, Ishida T, Fukunaga M, Fukuhara T, Minato H, Nakajima T, Yonezawa S, Kuroda M, Yamasaki F, Toyoshima S, Hashimoto H.

Am J Surg Pathol. 2006 Sep;30(9):1077-84.

PMID:
16931951
10.

Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion.

Stockman DL, Ali SM, He J, Ross JS, Meis JM.

Hum Pathol. 2014 Oct;45(10):2173-8. doi: 10.1016/j.humpath.2014.05.006. Epub 2014 Jun 2.

PMID:
25123073
11.

Low-grade fibromyxoid sarcoma with nuclear pleomorphism arising in the subcutis of a child.

Sedrak MP, Parker DC, Gardner JM.

J Cutan Pathol. 2014 Feb;41(2):134-8. doi: 10.1111/cup.12245. Epub 2013 Nov 5.

PMID:
24188507
12.

Low-grade fibromyxoid sarcoma arising in the big toe.

Kusumi T, Nishikawa S, Tanaka M, Ogawa T, Jin H, Sato F, Toh S, Hasegawa T, Kijima H.

Pathol Int. 2005 Dec;55(12):802-6.

PMID:
16287497
13.

Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.

Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N, Mertens F.

Cancer Genet Cytogenet. 2010 Jun;199(2):143-6. doi: 10.1016/j.cancergencyto.2010.02.011.

PMID:
20471519
14.

MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.

Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL.

Am J Surg Pathol. 2012 Oct;36(10):1444-51. doi: 10.1097/PAS.0b013e3182562bf8.

PMID:
22982887
16.

The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.

Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjö O, Rydholm A, Isaksson M, Mandahl N, Mertens F.

Genes Chromosomes Cancer. 2004 Jul;40(3):218-28.

PMID:
15139001
17.

Low-grade fibromyxoid sarcoma: a brief review.

Vernon SE, Bejarano PA.

Arch Pathol Lab Med. 2006 Sep;130(9):1358-60. Review.

PMID:
16948525
18.

A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma.

Debelenko LV, McGregor LM, Shivakumar BR, Dorfman HD, Raimondi SC.

Genes Chromosomes Cancer. 2011 Dec;50(12):1054-62. doi: 10.1002/gcc.20923. Epub 2011 Aug 24.

PMID:
21987447
19.

FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.

Patel RM, Downs-Kelly E, Dandekar MN, Fanburg-Smith JC, Billings SD, Tubbs RR, Goldblum JR.

Am J Dermatopathol. 2011 Apr;33(2):140-3. doi: 10.1097/IAE.0b013e318176de80.

PMID:
21399449
20.

DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.

Thway K, Ng W, Benson C, Chapman J, Fisher C.

Int J Surg Pathol. 2015 Sep;23(6):454-60. doi: 10.1177/1066896915593801. Epub 2015 Jul 1.

PMID:
26135531

Supplemental Content

Support Center